论文信息 - miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression. - 字舞流文

miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression.

R. Cohen | P. Leedman | D. Beveridge | Michael R. Epis | L. Stuart | K. Giles | J. Bentel | Kirsty L. Richardson | P. Candy | Lisa M. Stuart